comprehensive -WSS

comprehensive

author：entertainment 2025-09-29 23:04:31 - browse：745

How does a drug industry lobbying group move forward after years of upheaval, including having four CEOs in four years?

This week on “The Readout LOUD,” STAT’s Chief Washington Correspondent Rachel Cohrs Zhang joins us to discuss the layoffs at trade group BIO and how things may be changing at the trade group. We also invite STAT reporter Eric Boodman on to talk about his new investigative series of stories exploring how Black women with sickle cell disease were coerced into getting sterilized.

To read the first article in the Coercive Care investigative series and find future installments, go here; For more on the layoffs at BIO, go here; To keep tabs on health policy and BIO’s reorganization, sign up for the D.C. Diagnosis newsletter here; And you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Activists slam private health insurers over coverage restrictions
Next article： EpiPen alternative approval delay highlights citizen petition issue

Wikipedia

WSS

Second xenotransplant done with gene

What Congress can do to address the rural doctor shortage

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Biohaven protein

It's been 20 years since Dolly the sheep. Where's my clone?

entertainment

comprehensive

hotspot

Medicare details structure of new drug price negotiation program

Microbiome research is starting to find links to chronic diseases

The high cost of giving birth even with insurance

Microbiome research is starting to find links to chronic diseases

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Health insurers say they are turning to AI to cut costs, improve care

Apple is now the first public company to be valued at $3 trillion

CommonSpirit Health keeps growing, even as it loses money

focus

Adam's Biotech Scorecard: Do Sarepta's exon

CDC advisers recommend seasonal use of Pfizer RSV shot

First Opinion Podcast: What happens when kids become caregivers?

Lab trade group sues FDA to halt regulation of lab

David Sabatini, ex

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

knowledge

Wikipedia

Wikipedia

leisure time